Bristol Myers Reveals Plans for R&D Facilities

lawrenceville

NEW YORK — Bristol-Myers Squibb Company (BMY) announced a revamp of its research and development facilities across the country. The company will maintain its R&D hubs in Central New Jersey, the San Francisco Bay Area and Cambridge, MA while further integrating biologics development with clinical manufacturing at key sites to foster greater speed and collaboration. The changes are part of a …

Read More

Pfizer Decides Not to Split Up

NEW YORK — Pfizer Inc. announced that, after evaluation and careful consideration, the company’s Board of Directors and Executive Leadership Team have decided not to split Pfizer Innovative Health and Pfizer Essential Health into two, separate publicly traded companies at this time. The decision goes against corporate trends to split large companies into two separate …

Read More

Pfizer to Buy Medivation for $14 Billion

NEW YORK — Pfizer Inc. (NYSE:PFE) announced it will acquire Medivation (NASDAQ:MDVN) , a biopharmaceutical company focused on developing and commercializing small molecules for oncology, for $81.50 a share in cash for a total value of approximately $14 billion. Shares in Medivation were trading at over $80 dollar today, up over $13 from Friday’s closing …

Read More

Pfizer Completes Acquisition of Anacor

NEW YORK — Pfizer Inc. announced that it has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to receive $99.25 net in cash (without interest but subject to required withholding of taxes). “Now that Anacor is part …

Read More

GW Pharmaceuticals Stock Soars 120%

GW Pharmaceuticals, a British-based company, saw its shares more than double after it announced positive trials for a new medicine to treat epilepsy that is derived from marijuana plants. Shares in GW Pharmaceuticals finished the day at $84.71, up $46.25 for a 120.25% gain. The company has been focused on medicine from its proprietary cannabinoid …

Read More